These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10612019)

  • 41. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G; Rubessa F
    Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
    Wu Z; Razzak M; Tucker IG; Medlicott NJ
    J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solubilization of the neutral and charged forms of 2,4,6-trichlorophenol by beta-cyclodextrin, methyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in water.
    Hanna K; de Brauer C; Germain P
    J Hazard Mater; 2003 Jun; 100(1-3):109-16. PubMed ID: 12835016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
    Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
    Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inclusion complexation of nimesulide with beta-cyclodextrins.
    Vavia PR; Adhage NA
    Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of an inclusion complex of ethyl benzoate with hydroxypropyl-β-cyclodextrin.
    Yuan C; Lu Z; Jin Z
    Food Chem; 2014; 152():140-5. PubMed ID: 24444918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole.
    Mansuri S; Kesharwani P; Tekade RK; Jain NK
    Eur J Pharm Biopharm; 2016 May; 102():202-13. PubMed ID: 26563727
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of albendazole efficacy against enteral, but not against parenteral stages of Trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone.
    Lopez ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Chemotherapy; 1997; 43(6):430-5. PubMed ID: 9395857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.
    Usayapant A; Karara AH; Narurkar MM
    Pharm Res; 1991 Dec; 8(12):1495-9. PubMed ID: 1808612
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics.
    Lin SY; Yang JC
    Pharm Weekbl Sci; 1986 Aug; 8(4):223-8. PubMed ID: 3763366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preparation, identification and inclusion actions of irisquinone hydroxypropyl-beta-cyclodextrin inclusion complex].
    Zhang XN; Yan XY; Tang LH; Gong JH; Zhang Q
    Yao Xue Xue Bao; 2005 Apr; 40(4):369-72. PubMed ID: 16011270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.
    Lu Y; Zhang T; Tao J; Ji G; Wang S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery.
    Tenjarla S; Puranajoti P; Kasina R; Mandal T
    J Pharm Sci; 1998 Apr; 87(4):425-9. PubMed ID: 9548893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
    Cavalli R; Peira E; Caputo O; Gasco MR
    Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.